147 related articles for article (PubMed ID: 38702615)
1. The association between the triglyceride-glucose index and in-stent restenosis in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
Jiang H; Liu Y; Guo H; Liu Z; Li Z
BMC Cardiovasc Disord; 2024 May; 24(1):234. PubMed ID: 38702615
[TBL] [Abstract][Full Text] [Related]
2. Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents.
Zhu Y; Liu K; Chen M; Liu Y; Gao A; Hu C; Li H; Zhu H; Han H; Zhang J; Zhao Y
Cardiovasc Diabetol; 2021 Jul; 20(1):137. PubMed ID: 34238294
[TBL] [Abstract][Full Text] [Related]
3. Triglyceride-glucose index for predicting repeat revascularization and in-stent restenosis in patients with chronic coronary syndrome undergoing percutaneous coronary intervention.
Guo X; Shen R; Yan S; Su Y; Ma L
Cardiovasc Diabetol; 2023 Mar; 22(1):43. PubMed ID: 36864455
[TBL] [Abstract][Full Text] [Related]
4. Triglyceride-glucose index and coronary artery disease: a systematic review and meta-analysis of risk, severity, and prognosis.
Liang S; Wang C; Zhang J; Liu Z; Bai Y; Chen Z; Huang H; He Y
Cardiovasc Diabetol; 2023 Jul; 22(1):170. PubMed ID: 37415168
[TBL] [Abstract][Full Text] [Related]
5. Triglyceride-glucose index is associated with recurrent revascularization in patients with type 2 diabetes mellitus after percutaneous coronary intervention.
Chen Q; Xiong S; Zhang Z; Yu X; Chen Y; Ye T; Yang S; Qi L; Chen X; Liu H; Zheng J; Cai L
Cardiovasc Diabetol; 2023 Oct; 22(1):284. PubMed ID: 37865753
[TBL] [Abstract][Full Text] [Related]
6. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up.
Zhao LP; Xu WT; Wang L; Li H; Shao CL; Gu HB; Chan SP; Xu HF; Yang XJ
Coron Artery Dis; 2015 Jan; 26(1):5-10. PubMed ID: 25211654
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance, coronary artery lesion complexity and adverse cardiovascular outcomes in patients with acute coronary syndrome.
Chen Q; Xiong S; Ye T; Gao Y; Wang J; Li X; Li Y; Cui C; Liu H; Zhang Z; Cai L; Zheng J
Cardiovasc Diabetol; 2024 May; 23(1):172. PubMed ID: 38755609
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of triglyceride-glucose index in patients with chronic coronary syndrome undergoing percutaneous coronary intervention.
Tao S; Yu L; Li J; Xie Z; Huang L; Yang D; Tan Y; Zhang W; Huang X; Xue T
Cardiovasc Diabetol; 2023 Nov; 22(1):322. PubMed ID: 38017540
[TBL] [Abstract][Full Text] [Related]
9. Association of high level of hs-CRP with in-stent restenosis: A case-control study.
Baktashian M; Saffar Soflaei S; Kosari N; Salehi M; Khosravi A; Ahmadinejad M; Moohebati M; Ebrahimi M; Rahmani F; Khameneh-Bagheri R; Ahmadi M; Sadabadi F; Tayefi M; Bazhdanzadeh S; Ferns GA; Hashemi SM; Pasdar A; Ghayour-Mobarhan M
Cardiovasc Revasc Med; 2019 Jul; 20(7):583-587. PubMed ID: 30232022
[TBL] [Abstract][Full Text] [Related]
10. Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study.
Qin Z; Zhou K; Li YP; Wang JL; Cheng WJ; Hu CP; Shi C; He H; Zhou YJ
Cardiovasc Diabetol; 2019 Jan; 18(1):11. PubMed ID: 30691501
[TBL] [Abstract][Full Text] [Related]
11. FGF-23 correlates with endocrine and metabolism dysregulation, worse cardiac and renal function, inflammation level, stenosis degree, and independently predicts in-stent restenosis risk in coronary heart disease patients underwent drug-eluting-stent PCI.
Song T; Fu Y; Wang Y; Li W; Zhao J; Wang X; Wang H; Zhao Y; Fu X
BMC Cardiovasc Disord; 2021 Jan; 21(1):24. PubMed ID: 33413149
[TBL] [Abstract][Full Text] [Related]
12. Association between oral infections, triglyceride-glucose index, and in-stent restenosis.
Wu Y; Du L; Fan M; Chen X; Tang Y; Wang Y; Wang K; Wang S; Li G
Oral Dis; 2023 Nov; 29(8):3698-3706. PubMed ID: 36321885
[TBL] [Abstract][Full Text] [Related]
13. Coronary CT angiography-derived quantitative markers for predicting in-stent restenosis.
Tesche C; De Cecco CN; Vliegenthart R; Duguay TM; Stubenrauch AC; Rosenberg RD; Varga-Szemes A; Bayer RR; Yang J; Ebersberger U; Baquet M; Jochheim D; Hoffmann E; Steinberg DH; Chiaramida SA; Schoepf UJ
J Cardiovasc Comput Tomogr; 2016; 10(5):377-83. PubMed ID: 27431607
[TBL] [Abstract][Full Text] [Related]
14. Impact of Insulin Resistance on Neointimal Tissue Proliferation after 2nd-Generation Drug-Eluting Stent Implantation.
Komatsu T; Yaguchi I; Komatsu S; Nakahara S; Kobayashi S; Sakai Y; Taguchi I
Tex Heart Inst J; 2015 Aug; 42(4):327-32. PubMed ID: 26413014
[TBL] [Abstract][Full Text] [Related]
15. Visit-to-visit HbA
Yang CD; Shen Y; Lu L; Yang ZK; Hu J; Zhang RY; Shen WF; Ding FH; Wang XQ
Cardiovasc Diabetol; 2020 Sep; 19(1):133. PubMed ID: 32887588
[TBL] [Abstract][Full Text] [Related]
16. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome.
Ma X; Dong L; Shao Q; Cheng Y; Lv S; Sun Y; Shen H; Wang Z; Zhou Y; Liu X
Cardiovasc Diabetol; 2020 Mar; 19(1):31. PubMed ID: 32156279
[TBL] [Abstract][Full Text] [Related]
17. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention.
Luo E; Wang D; Yan G; Qiao Y; Liu B; Hou J; Tang C
Cardiovasc Diabetol; 2019 Nov; 18(1):150. PubMed ID: 31722708
[TBL] [Abstract][Full Text] [Related]
18. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China.
Hu C; Zhang J; Liu J; Liu Y; Gao A; Zhu Y; Zhao Y
Cardiovasc Diabetol; 2020 Jul; 19(1):116. PubMed ID: 32703284
[TBL] [Abstract][Full Text] [Related]
19. The association between triglyceride-glucose index and major adverse cardiovascular events in patients with acute coronary syndrome - dose-response meta-analysis.
Akbar MR; Pranata R; Wibowo A; Irvan ; Sihite TA; Martha JW
Nutr Metab Cardiovasc Dis; 2021 Oct; 31(11):3024-3030. PubMed ID: 34625361
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study.
Sasso FC; Pafundi PC; Marfella R; Calabrò P; Piscione F; Furbatto F; Esposito G; Galiero R; Gragnano F; Rinaldi L; Salvatore T; D'Amico M; Adinolfi LE; Sardu C
Cardiovasc Diabetol; 2019 Mar; 18(1):24. PubMed ID: 30832662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]